Baudax Bio, Inc. (BXRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Baudax Bio Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.021M |
| June 30, 2023 | 0.142M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.02M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 10.02M |
| September 30, 2021 | 2.006M |
| June 30, 2021 | -4.655M |
| March 31, 2021 | -7.568M |
| December 31, 2020 | -0.332M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.307M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.314M |
| September 30, 2019 | -0.081M |
| June 30, 2019 | -1.356M |
| March 31, 2019 | -0.361M |
| December 31, 2018 | -1.252M |
| September 30, 2018 | -0.34M |
| June 30, 2018 | -0.537M |
| March 31, 2018 | -1.323M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
| Johnson & Johnson | -1.11B |
| Eli Lilly & Co. | -15.40B |